Security key
320703408
Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI)
CUSIP: 320703408
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 7,142,857
- Total 13F shares
- 2,007,879
- Share change
- +1,559,557
- Total reported value
- $478,788
- Price per share
- $0.24
- Number of holders
- 27
- Value change
- +$226,762
- Number of buys
- 12
- Number of sells
- 8
Report period
Q1 2026
Institutions
27
Top holders
10
CLDI full security history
Previous quarter: Q4 2025
Calidi Biotherapeutics, Inc. SEC filings
Calidi Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 320703408
Recent filing periods:
Top shareholders of CLDI - Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
10%
|
1,111,732
|
$655,922 | -$1,326,278 | 31 Mar 2026 | |
| Gavrilov Ognian Anguelov |
13D/G
|
— |
0.3%
|
20,000
|
$6,600 | -$224,400 | 31 Mar 2026 | |
| Lincoln Alternative Strategies LLC |
3/4/5
|
10%+ Owner |
6.6%
|
730,000
|
$430,700 | — | 20 Aug 2025 | |
| Allan Camaisa |
3/4/5
|
Director |
1.1%
|
76,952
|
$111,965 | -$1,237 | 12 Dec 2025 | |
| DRW Securities, LLC |
13F
|
Company |
2.1%
|
147,767
|
$172,887 | — | 31 Dec 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
1.2%
|
83,523
|
$97,722 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.59%
|
41,929
|
$49,056 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.49%
|
34,728
|
$40,632 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.31%
|
22,013
|
$25,755 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.3%
|
21,243
|
$25,000 | — | 31 Dec 2025 | |
| RS CRUM INC. |
13F
|
Company |
0.28%
|
20,256
|
$23,700 | — | 31 Dec 2025 | |
| Belpointe Asset Management LLC |
13F
|
Company |
0.28%
|
19,971
|
$23,366 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.25%
|
17,758
|
$20,777 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.16%
|
11,491
|
$13,444 | — | 31 Dec 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0.14%
|
10,000
|
$11,700 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
7,514
|
$8,792 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.04%
|
2,774
|
$3,246 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.03%
|
2,106
|
$2,463 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
1,467
|
$1,716 | — | 31 Dec 2025 | |
| Apollo Management Holdings, L.P. |
13F
|
Company |
0.01%
|
1,042
|
$1,219 | — | 31 Dec 2025 | |
| Finepoint Capital LP |
13F
|
Company |
0.01%
|
1,042
|
$1,219 | — | 31 Dec 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
1,042
|
$1,218 | — | 31 Dec 2025 | |
| BARRETT & COMPANY, INC. |
13F
|
Company |
0%
|
292
|
$342 | — | 31 Dec 2025 | |
| Tradewinds Capital Management, LLC |
13F
|
Company |
0%
|
101
|
$119 | — | 31 Dec 2025 | |
| Reyes Financial Architecture, Inc. |
13F
|
Company |
0%
|
100
|
$117 | — | 31 Dec 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
46
|
$54 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
46
|
$53 | — | 31 Dec 2025 | |
| CVA Family Office, LLC |
13F
|
Company |
0%
|
42
|
$49 | — | 31 Dec 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
28
|
$33 | — | 31 Dec 2025 | |
| EVERMAY WEALTH MANAGEMENT LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2025 | |
| Polar Asset Management Partners Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
412,800
|
$4,330,272 | — | 19 Oct 2022 | |
| First Light Acquisition Group, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,931,852
|
— | — | 16 Jun 2023 | |
| Stephen Thesing |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
471,544
|
$848,779 | — | 12 Sep 2023 | |
| Boris Radoslavov Minev |
3/4/5
|
Interim Chief Medical Officer |
—
mixed-class rows
|
455,818
mixed-class rows
|
$764,024 | — | 17 Jun 2024 | |
| Thomas A. Vecchiolla |
3/4/5
|
Director |
—
mixed-class rows
|
781,459
mixed-class rows
|
$657,189 | — | 21 Dec 2023 | |
| Tony T. Kalajian |
3/4/5
|
Chief Acctg Officer, Int. CFO |
—
class O/S missing
|
278,790
|
$501,822 | — | 12 Sep 2023 | |
| Heehyoung Lee |
3/4/5
|
Director, Former Director |
—
class O/S missing
|
246,720
|
$444,096 | — | 10 Oct 2023 | |
| Wendy Pizarro Campbell |
3/4/5
|
Chief Admin. and Legal Officer |
—
mixed-class rows
|
222,374
mixed-class rows
|
$292,273 | — | 17 Jun 2024 | |
| Alfonso G. Zulueta |
3/4/5
|
Director |
—
class O/S missing
|
133,301
|
$239,942 | — | 21 Dec 2023 | |
| Scott Leftwich |
3/4/5
|
Director |
—
mixed-class rows
|
408,709
mixed-class rows
|
$86,511 | — | 21 Aug 2025 | |
| Amish Patel |
3/4/5
|
VP of Technical Operations |
—
class O/S missing
|
29,303
|
$52,745 | — | 12 Sep 2023 | |
| George K. Ng |
3/4/5
|
Director |
—
class O/S missing
|
28,092
|
$50,566 | — | 12 Sep 2023 | |
| James A. Schoeneck |
3/4/5
|
Director |
—
mixed-class rows
|
324,007
mixed-class rows
|
$49,862 | — | 21 Aug 2025 | |
| Alan R. Stewart |
3/4/5
|
Director |
—
mixed-class rows
|
166,054
mixed-class rows
|
$46,941 | — | 09 Jul 2025 | |
| David Sans |
3/4/5
|
Chief of Corporate Development |
—
class O/S missing
|
18,314
|
$32,965 | — | 12 Sep 2023 | |
| Eric E. Poma |
3/4/5
|
Chief Executive Officer |
—
mixed-class rows
|
786,412
mixed-class rows
|
$14,750 | — | 03 Sep 2025 | |
| Andrew C. Jackson |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
35,000
mixed-class rows
|
$1,475 | — | 03 Sep 2025 | |
| George Peoples |
3/4/5
|
Director |
—
class O/S missing
|
137,078
|
— | — | 09 Jul 2025 | |
| Antonio Fernandez Santidrian |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
35,000
|
— | — | 03 Sep 2025 |
Institutional Holders of Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) as of Q1 2026
As of 31 Mar 2026,
Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,007,879 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, Warberg Asset Management LLC, HighTower Advisors, LLC, Virtu Financial LLC, GEODE CAPITAL MANAGEMENT, LLC, RS CRUM INC., Arax Advisory Partners, JANE STREET GROUP, LLC, and VANGUARD CAPITAL MANAGEMENT LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
27
Q1 2026 holders
27
Holder diff
0
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.